Elizabeth M. Perpetua, DNP, ACNP-BC, APHN-BC, FACC
Dr. Elizabeth Perpetua is a nurse practitioner, researcher, and the Founder of Empath Health Services LLC. She is nationally recognized for her expertise in patient-centered, team-based systems of care for valvular, structural, and coronary heart disease.
Since 2008, she has led in the development of clinical programs, education, and best practices for the care of patients undergoing transcatheter valve and structural heart procedures including TAVR, TEER, TMVR, TTVR, LAAO, PFO/ASD closure. She is a Lecturer and Affiliate Instructor at University of Washington, a Board of Directors Member of Heart Valve Voice US, and a Scientific Advisory Group Member of American Heart Association’s Target Aortic Stenosis Quality and Implementation Science Initiative.
Dr. Perpetua is a co-founder the ACC Cardiovascular Team Structural Heart Workgroup and lead for the Publications and Research subcommittee. She recently served as Chair of an ACC Expert Panel on Shared Decision Making in Team-Based Cardiovascular Care. Dr. Perpetua received the Master of Nursing (MN) and Doctor of Nursing Practice (DNP) degrees at University of Washington.
Dhaval Kolte, MBBS, PhD, MPH, FACC, FASE, FSCAI
Dr. Dhaval Kolte is a Structural Interventional Cardiologist at Massachusetts General Hospital (MGH) and an Assistant Professor of Medicine at Harvard Medical School. He is also an Affiliate Faculty at The Mongan Institute at MGH and Smith Center for Outcomes Research in Cardiology at BIDMC.
Dr. Kolte's research interest is in quality of care, outcomes, and comparative effectiveness of transcatheter heart valve interventions. Specifically, his current research, funded by the NIH/NHLBI, is focused on understanding the reasons underlying hospital-level variation in outcomes of transcatheter aortic valve replacement (TAVR) and identifying modifiable practices and processes of care associated with improved patient outcomes.
Dr. Kolte’s clinical area of expertise is in interventional cardiology, with an emphasis on structural heart disease and transcatheter aortic, mitral, and tricuspid valve interventions.
Rakesh M. Suri, MD, DPhil
Dr. Rakesh Suri is a globally recognized thought leader and pioneering cardiac surgeon with expertise in heart valve disease, robotics, transcatheter technology and complex multivalve pathology. He is currently Head of Robotic Cardiac Surgery at Corewell Health.
Dr. Suri served as the first President of International Operations at the Cleveland Clinic leading One Cleveland Clinic in the United States and abroad, specifically as President and Chief Executive Officer of Cleveland Clinic Abu Dhabi and Executive Team member of the Cleveland Clinic Enterprise.
Dr. Suri was also a a consultant in the Division of Cardiovascular Surgery, Professor of Surgery and Chair of the Enterprise Robotic Practice at Mayo Clinic, Director of the Cardiovascular Fellowship Program at Mayo Clinic and past President of the Heart Valve Society.
Dr. Suri earned his undergraduate degree at Queen’s University in Kingston, Ontario, Canada, medical degree with honors from the University of Toronto and a doctorate at Magdalen College, Oxford, UK, as a Rhodes Scholar. He completed thoracic surgical residency at Mayo Clinic College of Medicine and is board-certified in both General Surgery and Cardiothoracic Surgery.
Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI
Dr. Sammy Elmariah is an interventional cardiologist who cares for adults with heart valve disease, coronary artery disease and congenital heart disease. He is an expert in transcatheter (minimally invasive) heart valve procedures, including transcatheter aortic valve replacement (TAVR), transcatheter edge-to-edge mitral valve repair (TEER or MitraClip) and transcatheter mitral valve replacement (TMVR). He also specializes in research is to advance transcatheter and other surgical procedures for heart valve disease in order to maximize patient health and outcomes. His research team is funded by the National Institutes of Health, American Heart Association, U.S. Department of Defense and several industry partners.
Dr. Elmariah earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania. He completed fellowships in interventional cardiology and structural heart disease at Massachusetts General Hospital, an affiliate of Harvard Medical School. He also has a master of public health degree from the Harvard T.H. Chan School of Public Health.
Megan Coylewright, MD, MPH, FACC, FSCAI
Dr. Megan Coylewright is a structural interventional cardiologist known for her research focused on heart teams and shared decision making. Dr. Coylewright is the Editor of the American College of Cardiology (ACC) CardioSmart/Patient Voice Program and an active volunteer with the Society of Cardiovascular Angiography and Interventions (SCAI).
Dr. Coylewright completed her medical school, residency, and Master of Public Health training at Johns Hopkins, and cardiovascular training at Mayo Clinic in her home state of Minnesota. Dr. Coylewright’s experience building structural programs has reached from the northeast to the deep south, with expertise in team building alongside rapid clinical growth.
She serves on the Executive Steering Committees for global device trials focused on TAVR, LAAO and interatrial shunts and leads research on optimizing heart team and shared decision making implementation.